Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Eflapegrastim

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Spectrum's Biologic Rolvedon (Eflapegrastim) Receives Approval in the U.S.
    Spectrum's Biologic Rolvedon (Eflapegrastim) Receives Approval in the U.S.

    16 Jun 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761148

    FDA
    16 Jun 2023
    Share Share
    Spectrum Receives Permanent J-Code for ROLVEDON Injection from U.S. CMS
    Spectrum Receives Permanent J-Code for ROLVEDON Injection from U.S. CMS

    08 Feb 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230208005310/en

    BUSINESSWIRE
    08 Feb 2023
    Share Share
    Spectrum Pharmaceuticals Provides Update on ROLVEDON Injection
    Spectrum Pharmaceuticals Provides Update on ROLVEDON Injection

    31 Jan 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230131005344/en

    BUSINESSWIRE
    31 Jan 2023
    Share Share
    Spectrum Pharma’s ROLVEDON Injection Added to NCCN Supportive Care Guidelines
    Spectrum Pharma’s ROLVEDON Injection Added to NCCN Supportive Care Guidelines

    06 Dec 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20221206005351/en

    BUSINESSWIRE
    06 Dec 2022
    Share Share
    Spectrum Pharmaceuticals Receives FDA Approval for ROLVEDON Injection
    Spectrum Pharmaceuticals Receives FDA Approval for ROLVEDON Injection

    09 Sep 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220909005522/en

    BUSINESSWIRE
    09 Sep 2022
    Share Share
    Spectrum's Biologic Rolvedon (Eflapegrastim) Receives Approval in the U.S.
    Spectrum's Biologic Rolvedon (Eflapegrastim) Receives Approval in the U.S.

    09 Sep 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761148

    FDA
    09 Sep 2022
    Share Share